Norwegian Medicines Agency

News and Video Search Results

News coverage

IAVI to Accelerate Promising Investigational Sudan Ebolavirus Vaccine Development for Potential Outbreak Research and Response

IAVI to Accelerate Promising Investigational Sudan Ebolavirus Vaccine Development for Potential Outbreak Research and Response

Accesswire 25 Oct 2022

*Merck will provide the investigational vaccine based on a proven platform technology*

*NEW YORK, NY / ACCESSWIRE /..

Ultimovacs ASA Reports First Quarter 2024 Financial Results and Provides General Business Update
GlobeNewswire 07 May 2024
Ultimovacs Receives EMA Orphan Drug Designation for UV1 Cancer Vaccine for the Treatment of Mesothelioma
GlobeNewswire 19 Feb 2024
Ultimovacs Receives FDA Orphan Drug Designation for the UV1 Cancer Vaccine for Treatment of Mesothelioma
GlobeNewswire 09 Oct 2023
Press Release: Acoziborole: Investigational single-dose oral treatment raises hope for elimination of sleeping sickness in Africa
GlobeNewswire 30 Nov 2022

0 shares 1 views

You might like

Norwegian Medicines Agency media coverage

Norway is open to 4th COVID-19 shot to people over 80

SeattlePI.com 20 Apr 2022

COPENHAGEN, Denmark (AP) — Norwegian health authorities said Wednesday they are open to giving people aged 80 and above a booster..

Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
GlobeNewswire 09 Mar 2022
PCI Biotech: Update on regulatory interactions for the RELEASE trial
GlobeNewswire 07 Dec 2021
Nobel Peace Prize Awarded To Journalists Ressa And Muratov
Newsy 08 Oct 2021
Hofseth Biocare ASA: HBC ONBOARDS EX-NOVARTIS AND EX-PFIZER SENIOR REGULATORY AFFAIRS PROFESSIONAL, DR ZUBAIR HUSSAIN
GlobeNewswire 22 Sep 2021

Advertisement

More coverage

'I Just Cry’: Dying of Hunger in Ethiopia’s Blockaded Tigray

In parts of Ethiopia’s Tigray region, people now eat only green leaves for days. At a health center last week, a mother and her..

VOA News 20 Sep 2021